All Blogs

Sep 09, 2021

Roche’s Genentech taps Adaptimmune for T-Cell Therapy Collaboration for USD 3 Billion A collaboration valued more than USD 3 billion, Genentech, a member of the Roche Group, declared it will collaborate with Adaptimmune for developing and commercializing allogeneic T-cell therapies to treat multiple cancer indic...

Jul 21, 2026

Summary Systemic lupus erythematosus, once considered highly unpredictable and difficult to treat, is undergoing a major therapeutic transformation driven by biologics, small molecules, and cell-based therapies. The SLE market is valued at around USD 3 billion in 2025 across the 7MM and is projected to grow ...

Sep 08, 2021

Consultancy comes from the Latin consultare, which means "to discuss." Usually, a professional providing expert advice in a specific area can be called a consultant, a group of individuals - consultancy. Business Consultancy requires dealing with a broad range of activities, and every firm or individual involved...

Aug 01, 2025

In today's hyper-competitive and information-saturated global economy, companies across sectors are constantly challenged to make high-stakes decisions at speed and scale. Whether it's an established multinational corporation or a nimble start-up, navigating complexity often leads to operational delays, financial m...

Sep 07, 2021

Pfizer’s RSV Vaccine enters in the late-stage of clinical trials  As the battle to get an effective Respiratory Syncytial Virus (RSV) vaccine on the market heats up, Pfizer is launching a critical late-stage study of its experimental vaccine against a severe version of a cold virus that may cause pneumonia ...

Sep 06, 2021

Phenylketonuria is an inherited disorder characterized by the absence or deficiency of an enzyme called phenylalanine hydroxylase (PAH), responsible for processing the amino acid phenylalanine. The condition affects one in 13,500 to 19,000 newborns in the United States, says NORD. DelveInsight’s Phenylketonuria epi...

Jul 10, 2026

Summary Charcot-Marie-Tooth disease is genetically heterogeneous, with more than 100 genes associated with different CMT disease subtypes. Currently, no approved therapies are available for the treatment of CMT disease, leaving patients with limited treatment options. As a result, there remains a significant...

Sep 02, 2021

FDA awards Breakthrough Device Designation to Impella ECP  On August 18, 2021, Abiomed received breakthrough device designation from the United States Food and Drug Administration (FDA) for its Impella ECP expandable percutaneous heart pump, the world’s smallest heart pump and the first to be compatible wit...

Sep 01, 2021

Drones, also referred to as unmanned aerial vehicles (UAVs)/unpiloted aircraft, are remotely piloted to meet various needs. Drones are one of the emerging technologies that are reshaping the transportation system. Earlier, the main use of drones was for a military expedition, however, today the drones can be seen i...

Aug 31, 2021

FDA's Green Flag to Ascendis's Once-Weekly SKYTROFA for Treatment of Pediatric Growth Hormone Deficiency For the treatment of growth failure due to deficiency of growth hormones, the USFDA approved Ascendis Pharma's Skytrofa (lonapegsomatropin-tcgd) for children of one year and older suffering from an improper s...